INTRODUCTION: Primary progressive aphasia (PPA) is a clinically variable syndrome manifesting as slow progressive loss of speech and language with multiple underlying neurodegenerative pathologies. MATERIALS AND METHODS: We included data from nine PPA patients with available autopsies. We then retrospectively reviewed all available medical records, neuropsychology, and MRI results to confirm the corresponding subtypes of PPA and compared them with postmortem neuropathological results. RESULTS: Clinical presentations corresponded to the nonfluent/agrammatic variant in six cases, the semantic variant in one case, the logopenic variant in one case, and the mixed variant (concomitant nonfluent/agrammatic plus semantic variant) in one case. Patients with a broader clinical presentation, i.e., combining manifestations of one PPA subtype and symptoms of another PPA variant, had autopsy comorbidities showing multiple neurodegenerative disorders. Of the nine subjects enrolled in the study, Alzheimer's disease (AD) was found in eight cases; however, in only one case, AD was detected as an isolated neuropathological substrate of PPA. In eight brain samples, different comorbid neuropathologies were detected: three cases with comorbid AD and dementia with Lewy bodies, two cases with comorbid AD and TDP-43 pathology, one case with comorbid AD and complex tauopathies, and one case with comorbid AD with both tau and TDP-43 deposits. Finally, one case had comorbid tau and TDP-43 pathology but without comorbid AD pathology. CONCLUSIONS: Our observation suggests that PPA cases could be more heterogeneous in their etiology than previously thought and underlying neurodegenerative comorbidities should be considered in routine practice, especially if the clinical presentation of PPA is atypical.

1st Faculty of Medicine Charles University Prague Czech Republic

3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Communication Disorders Comenius University Bratislava Slovakia

Department of Neurology Thomayer University Hospital Prague Czech Republic

Department of Pathology and Molecular Medicine Thomayer University Hospital Prague Czech Republic

Department of Radiology Na Homolce Hospital Prague Czech Republic

Faculty of Nuclear Sciences and Physical Engineering Czech Technical University Prague Czech Republic

Zobrazit více v PubMed

Gorno-Tempini M. L., Hillis A. E., Weintraub S., et al. Classification of primary progressive aphasia and its variants. Neurology . 2011;76(11):1006–1014. doi: 10.1212/WNL.0b013e31821103e6. PubMed DOI PMC

Grossman M. Primary progressive aphasia: clinicopathological correlations. Nature Reviews. Neurology . 2010;6(2):88–97. doi: 10.1038/nrneurol.2009.216. PubMed DOI PMC

Ruksenaite J., Volkmer A., Jiang J., et al. Primary progressive aphasia: toward a pathophysiological synthesis. Current Neurology and Neuroscience Reports . 2021;21(3):p. 7. doi: 10.1007/s11910-021-01097-z. PubMed DOI PMC

Hickok G., Poeppel D. The cortical organization of speech processing. Nature Reviews. Neuroscience . 2007;8(5):393–402. doi: 10.1038/nrn2113. PubMed DOI

Friederici A. D. White-matter pathways for speech and language processing. Handbook of Clinical Neurology . 2015;129:177–186. doi: 10.1016/B978-0-444-62630-1.00010-X. PubMed DOI

Henry M. L., Wilson S. M., Babiak M. C., et al. Phonological processing in primary progressive aphasia. Journal of Cognitive Neuroscience . 2016;28(2):210–222. doi: 10.1162/jocn_a_00901. PubMed DOI PMC

Agosta F., Galantucci S., Canu E., et al. Disruption of structural connectivity along the dorsal and ventral language pathways in patients with nonfluent and semantic variant primary progressive aphasia: a DT MRI study and a literature review. Brain and Language . 2013;127(2):157–166. doi: 10.1016/j.bandl.2013.06.003. PubMed DOI

Galantucci S., Tartaglia M. C., Wilson S. M., et al. White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain . 2011;134(10):3011–3029. doi: 10.1093/brain/awr099. PubMed DOI PMC

Keller J., Kavkova A., Matej R., Cséfalvay Z., Rusina R. Corpus callosum hypersignals and focal atrophy: neuroimaging findings in globular glial tauopathy type I. European Journal of Neurology . 2022;29(1):324–328. doi: 10.1111/ene.15090. PubMed DOI PMC

Bettcher B., Sturm V. E. Neuropsychological assessment of primary progressive aphasia (PPA) Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders . 2014;24(4):128–136. doi: 10.1044/nnsld24.4.128. DOI

Miller Z. A., Miller B. L. Artistic creativity and dementia. Progress in Brain Research . 2013;204:99–112. doi: 10.1016/B978-0-444-63287-6.00005-1. PubMed DOI

Butts A. M., Machulda M. M., Duffy J. R., Strand E. A., Whitwell J. L., Josephs K. A. Neuropsychological profiles differ among the three variants of primary progressive aphasia. Journal of the International Neuropsychological Society . 2015;21(6):429–435. doi: 10.1017/S1355617715000399. PubMed DOI PMC

Ramanan S., Marstaller L., Hodges J. R., Piguet O., Irish M. Understanding the neural basis of episodic amnesia in logopenic progressive aphasia: a multimodal neuroimaging study. Cortex . 2020;125:272–287. doi: 10.1016/j.cortex.2019.12.026. PubMed DOI

Ramanan S., Foxe D., El-Omar H., et al. Evidence for a pervasive autobiographical memory impairment in logopenic progressive aphasia. Neurobiology of Aging . 2021;108:168–178. doi: 10.1016/j.neurobiolaging.2021.09.004. PubMed DOI

Watson C. L., Possin K., Allen I. E., et al. Visuospatial functioning in the primary progressive aphasias. Journal of the International Neuropsychological Society . 2018;24(3):259–268. doi: 10.1017/S1355617717000984. PubMed DOI PMC

Mackenzie I. R., Neumann M., Baborie A., et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica . 2011;122(1):111–113. doi: 10.1007/s00401-011-0845-8. PubMed DOI PMC

Bergeron D., Gorno-Tempini M. L., Rabinovici G. D., et al. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Annals of Neurology . 2018;84(5):729–740. doi: 10.1002/ana.25333. PubMed DOI PMC

Rohrer J. D., Lashley T., Schott J. M., et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain . 2011;134(9):2565–2581. doi: 10.1093/brain/awr198. PubMed DOI PMC

Mesulam M. M., Weintraub S., Rogalski E. J., Wieneke C., Geula C., Bigio E. H. Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain . 2014;137(4):1176–1192. doi: 10.1093/brain/awu024. PubMed DOI PMC

Spinelli E. G., Mandelli M. L., Miller Z. A., et al. Typical and atypical pathology in primary progressive aphasia variants. Annals of Neurology . 2017;81(3):430–443. doi: 10.1002/ana.24885. PubMed DOI PMC

Apple A. C., Mao Q., Bigio E., Bonakdarpour B. Sleep talking and primary progressive aphasia: case study and autopsy findings in a patient with logopenic primary progressive aphasia and dementia with Lewy bodies. BML Case Reports . 2019;12(5, article e228938) doi: 10.1136/bcr-2018-228938. PubMed DOI PMC

Kakinuma K., Narita W., Baba T., Iizuka O., Nishio Y., Suzuki K. “Semantic variant primary progressive aphasia” due to comorbidity of Lewy body disease and a previous cerebral venous infarction in the left anterior temporal lobe: a case report. Eneurologicalsci . 2021;22:p. 100318. doi: 10.1016/j.ensci.2021.100318. PubMed DOI PMC

Schneider J. A., Arvanitakis Z., Leurgans S. E., Bennett D. A. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Annals of Neurology . 2009;66(2):200–208. doi: 10.1002/ana.21706. PubMed DOI PMC

Gefen T., Ahmadian S. S., Mao Q., et al. Combined pathologies in FTLD-TDP types a and C. Journal of Neuropathology and Experimental Neurology . 2018;77(5):405–412. doi: 10.1093/jnen/nly018. PubMed DOI PMC

Caselli R. J., Beach T. G., Sue L. I., Connor D. J., Sabbagh M. N. Progressive aphasia with Lewy bodies. Dementia and Geriatric Cognitive Disorders . 2002;14(2):55–58. doi: 10.1159/000064925. PubMed DOI

Scheltens P., Leys D., Barkhof F., et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. Journal of Neurology, Neurosurgery, and Psychiatry . 1992;55(10):967–972. doi: 10.1136/jnnp.55.10.967. PubMed DOI PMC

Koedam E. L., Lehmann M., van der Flier W. M., et al. Visual assessment of posterior atrophy development of a MRI rating scale. European Radiology . 2011;21(12):2618–2625. doi: 10.1007/s00330-011-2205-4. PubMed DOI PMC

Fazekas F., Kleinert R., Offenbacher H., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology . 1993;43(9):1683–1689. doi: 10.1212/WNL.43.9.1683. PubMed DOI

Witelson S. F. Hand and sex differences in the isthmus and genu of the human corpus callosum. a postmortem morphological study. Brain . 1989;112(3):799–835. PubMed

Hofer S., Frahm J. Topography of the human corpus callosum revisited--comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage . 2006;32(3):989–994. doi: 10.1016/j.neuroimage.2006.05.044. PubMed DOI

Smith S. M., Jenkinson M., Woolrich M. W., et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage . 2004;23:S208–S219. doi: 10.1016/j.neuroimage.2004.07.051. PubMed DOI

Smith S. M. Fast robust automated brain extraction. Human Brain Mapping . 2002;17(3):143–155. doi: 10.1002/hbm.10062. PubMed DOI PMC

Behrens T. E., Woolrich M. W., Jenkinson M., et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magnetic Resonance in Medicine . 2003;50(5):1077–1088. doi: 10.1002/mrm.10609. PubMed DOI

Montine T. J., Phelps C. H., Beach T. G., et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathologica . 2012;123(1):1–11. doi: 10.1007/s00401-011-0910-3. PubMed DOI PMC

Stejskalova Z., Rohan Z., Rusina R., et al. Pyramidal system involvement in progressive supranuclear palsy – a clinicopathological correlation. BMC Neurology . 2019;19(1):p. 42. doi: 10.1186/s12883-019-1270-1. PubMed DOI PMC

Williams D. R., Holton J. L., Strand C., et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain . 2007;130(6):1566–1576. doi: 10.1093/brain/awm104. PubMed DOI

Kovacs G. G., Lukic M. J., Irwin D. J., et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathologica . 2020;140(2):99–119. doi: 10.1007/s00401-020-02158-2. PubMed DOI PMC

Ahmed Z., Bigio E. H., Budka H., et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathologica . 2013;126(4):537–544. doi: 10.1007/s00401-013-1171-0. PubMed DOI PMC

McKeith I. G., Boeve B. F., Dickson D. W., et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology . 2017;89(1):88–100. doi: 10.1212/WNL.0000000000004058. PubMed DOI PMC

Kovacs G. G., Ferrer I., Grinberg L. T., et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica . 2016;131(1):87–102. doi: 10.1007/s00401-015-1509-x. PubMed DOI PMC

Nelson P. T., Dickson D. W., Trojanowski J. Q., et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain . 2019;142(6):1503–1527. doi: 10.1093/brain/awz099. PubMed DOI PMC

Rusina R., Csefalvay Z., Kovacs G. G., Keller J., Javurkova A., Matej R. Globular glial tauopathy type I presenting as atypical progressive aphasia, with comorbid limbic-predominant age-related TDP-43 encephalopathy. Frontiers in Aging Neuroscience . 2019;11:p. 336. doi: 10.3389/fnagi.2019.00336. PubMed DOI PMC

Picková T., Matěj R., Bezdicek O., et al. Genetic Alzheimer disease and sporadic dementia with Lewy bodies: a comorbidity presenting as primary progressive aphasia. Cognitive and Behavioral Neurology . 2017;30(1):23–29. doi: 10.1097/WNN.0000000000000116. PubMed DOI

Mesulam M., Coventry C., Bigio E. H., et al. Nosology of primary progressive aphasia and the neuropathology of language. Advances in Experimental Medicine and Biology . 2021;1281:33–49. doi: 10.1007/978-3-030-51140-1_3. PubMed DOI PMC

Jack C. R., Jr., Albert M. S., Knopman D. S., et al. Introduction to the recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement . 2011;7(3):257–262. doi: 10.1016/j.jalz.2011.03.004. PubMed DOI PMC

Anderson T. J., MacAskill M. R. Eye movements in patients with neurodegenerative disorders. Nature Reviews. Neurology . 2013;9(2):74–85. doi: 10.1038/nrneurol.2012.273. PubMed DOI